Mela Sciences moves beyond skin cancer
This article was originally published in Clinica
Executive Summary
Mela Sciences has broadened its offering beyond melanoma detection with the acquisition of two dermatology assets, the XTRAC and VTRAC systems for treating psoriasis, vitiligo and other serious skin conditions, from PhotoMedex.